Kensuke Bekku

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial

Maria De Santis, Joan Palou Redorta, Hiroyuki Nishiyama et al. · The Lancet · 2025 · 47 citations · Full text

Medicine, Oncology, Urology +13

Inflammatory pseudotumor of the kidney with renal artery penetration

Yuko Nakamura, Masaki Urashima, Reisuke Nishihara et al. · Radiation Medicine · 2007 · 22 citations

Medicine, Pathology, Surgery +14

Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?

Kensuke Bekku, Takashi Saika, Yasuyuki Kobayashi et al. · International Journal of Clinical Oncology · 2011 · 19 citations · Full text

Medicine, Oncology, Surgery +13

Predictive factors for acute and late urinary toxicity after permanent interstitial brachytherapy in <scp>J</scp>apanese patients

Ryuta Tanimoto, Kensuke Bekku, Norihisa Katayama et al. · International Journal of Urology · 2013 · 14 citations

Medicine, Oncology, Urology +14

Trans men can achieve adequate muscular development through low‐dose testosterone therapy: A long‐term study on body composition changes

Yusuke Tominaga, Tomoko Kobayashi, Yuko Matsumoto et al. · Andrology · 2024 · 14 citations

Medicine, Endocrinology, Andrology +16